Biogen, headquartered in Cambridge, MA, is a global biotechnology company at the forefront of pioneering innovative solutions for a variety of diseases such as Alzheimer's Disease, Multiple Sclerosis, and Spinal Muscular Atrophy.
With a strong commitment to science and innovation, Biogen focuses on developing transformative medicines through research, clinical trials, and early access programs while also prioritizing corporate responsibility by promoting health equity, diversity, and environmental sustainability.